Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,117 | 13,291 | 12,598 | 5,876 | 16,944 |
| Marketable Securities | 34 | 33 | 32 | 31 | 33 |
| TOTAL | $9,182 | $18,912 | $13,619 | $6,904 | $17,715 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 0 | 5 |
| Intangibles | 0 | 0 | 0 | 21 | 28 |
| TOTAL | $N/A | $N/A | $N/A | $21 | $32 |
| Total Assets | $9,182 | $18,912 | $13,619 | $6,925 | $17,747 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,543 | 1,738 | 7,843 | 2,975 | 409 |
| Accrued Expenses | 7,868 | 481 | 1,507 | 3,438 | 520 |
| TOTAL | $10,412 | $2,218 | $9,350 | $6,413 | $929 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 29 | 205 | 516 | 1,859 | 11,158 |
| TOTAL | $29 | $205 | $516 | $1,859 | $11,158 |
| Total Liabilities | $10,441 | $2,423 | $9,866 | $8,272 | $12,087 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,968 | 1,308 | 758 | 343 | N/A |
| Retained earnings | -130,406 | -90,687 | -93,466 | -80,254 | -62,191 |
| Other shareholders' equity | -371 | -371 | -371 | -195 | -188 |
| TOTAL | $-1,259 | $16,488 | $3,753 | $-1,348 | $5,660 |
| Total Liabilities And Equity | $9,182 | $18,912 | $13,619 | $6,925 | $17,747 |